181 related articles for article (PubMed ID: 23276803)
21. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
22. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
23. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
[TBL] [Abstract][Full Text] [Related]
24. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
25. Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response.
Bani-Sadr F; Krastinova E; Fromentin D; Piroth L; Rosenthal E; Quertainmont Y; Perronne C; Cacoub P; Pol S; Carrat F;
J Viral Hepat; 2012 Jun; 19(6):431-5. PubMed ID: 22571905
[TBL] [Abstract][Full Text] [Related]
26. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M;
Antivir Ther; 2012; 17(7):1327-34. PubMed ID: 22948263
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
[TBL] [Abstract][Full Text] [Related]
28. Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Berenguer J; Alvarez-Pellicer J; Carrero A; Von Wichmann MA; López-Aldeguer J; Mallolas J; Galindo MJ; Van Den Eynde E; Téllez MJ; Quereda C; Tural C; Sanz J; Barros C; Santos I; Pulido F; Guardiola JM; Ortega E; Rubio R; Jusdado JJ; Montes ML; Gaspar G; Barquilla E; Bellón JM; González-García J;
J Hepatol; 2013 Jun; 58(6):1104-12. PubMed ID: 23395690
[TBL] [Abstract][Full Text] [Related]
29. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis.
Berenguer J; Zamora FX; Carrero A; Von Wichmann MA; Crespo M; López-Aldeguer J; Aldámiz-Echevarría T; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Esteban H; Bellón JM; González-García J;
J Acquir Immune Defic Syndr; 2014 Jul; 66(3):280-7. PubMed ID: 25157646
[TBL] [Abstract][Full Text] [Related]
30. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
31. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
33. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Macías J; Márquez M; Téllez F; Merino D; Jiménez-Aguilar P; López-Cortés LF; Ortega E; von Wichmann MA; Rivero A; Mancebo M; Santos J; Pérez-Pérez M; Suárez-Lozano I; Romero-Palacios A; Torres-Cornejo A; Pineda JA
Clin Infect Dis; 2013 Nov; 57(10):1401-8. PubMed ID: 23946224
[TBL] [Abstract][Full Text] [Related]
34. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
[TBL] [Abstract][Full Text] [Related]
35. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
Vergara S; Macías J; Rivero A; Gutiérrez-Valencia A; González-Serrano M; Merino D; Ríos MJ; García-García JA; Camacho A; López-Cortés L; Ruiz J; de la Torre J; Viciana P; Pineda JA;
Clin Infect Dis; 2007 Oct; 45(8):969-74. PubMed ID: 17879910
[TBL] [Abstract][Full Text] [Related]
36. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.
Suárez-Zarracina T; Valle-Garay E; Collazos J; Montes AH; Cárcaba V; Carton JA; Asensi V
J Viral Hepat; 2012 Oct; 19(10):685-93. PubMed ID: 22967099
[TBL] [Abstract][Full Text] [Related]
37. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
[TBL] [Abstract][Full Text] [Related]
38. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
39. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
